Beijing Bohui Innovation Technology Co Ltd (300318) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.027x

Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.46 Million ≈ $-9.14 Million USD) by net assets (CN¥2.29 Billion ≈ $334.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Bohui Innovation Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing Bohui Innovation Technology Co L total liabilities for a breakdown of total debt and financial obligations.

Beijing Bohui Innovation Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Bohui Innovation Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhejiang Kanglongda Special
SHG:603665
0.024x
Shanghai Canature Environmental
SHE:300272
0.029x
Yongji Printing Co Ltd
SHG:603058
0.005x
Newcapec Electronics Co Ltd
SHE:300248
0.022x
Pet Acquisition LLC
NASDAQ:WOOF
0.078x
Grupo Supervielle S.A. B
BA:SUPV
0.176x
Bravura Solutions Ltd
AU:BVS
0.471x
QuinStreet Inc
NASDAQ:QNST
0.073x

Annual Cash Flow Conversion Efficiency for Beijing Bohui Innovation Technology Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Bohui Innovation Technology Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 300318 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.35 Billion
≈ $343.75 Million
CN¥-38.69 Million
≈ $-5.66 Million
-0.016x -128.13%
2023-12-31 CN¥2.34 Billion
≈ $342.50 Million
CN¥137.02 Million
≈ $20.05 Million
0.059x +234.10%
2022-12-31 CN¥2.32 Billion
≈ $340.06 Million
CN¥40.72 Million
≈ $5.96 Million
0.018x +1740.95%
2021-12-31 CN¥932.75 Million
≈ $136.49 Million
CN¥887.78K
≈ $129.91K
0.001x -98.41%
2020-12-31 CN¥1.44 Billion
≈ $210.56 Million
CN¥86.14 Million
≈ $12.60 Million
0.060x +274.83%
2019-12-31 CN¥1.05 Billion
≈ $153.96 Million
CN¥-36.03 Million
≈ $-5.27 Million
-0.034x +49.38%
2018-12-31 CN¥1.24 Billion
≈ $182.03 Million
CN¥-84.15 Million
≈ $-12.31 Million
-0.068x -14.67%
2017-12-31 CN¥1.61 Billion
≈ $236.13 Million
CN¥-95.19 Million
≈ $-13.93 Million
-0.059x -215.34%
2016-12-31 CN¥1.52 Billion
≈ $223.07 Million
CN¥77.97 Million
≈ $11.41 Million
0.051x -26.21%
2015-12-31 CN¥1.28 Billion
≈ $187.79 Million
CN¥88.95 Million
≈ $13.02 Million
0.069x +62.20%
2014-12-31 CN¥726.57 Million
≈ $106.32 Million
CN¥31.05 Million
≈ $4.54 Million
0.043x -45.49%
2013-12-31 CN¥702.55 Million
≈ $102.81 Million
CN¥55.08 Million
≈ $8.06 Million
0.078x -15.69%
2012-12-31 CN¥658.98 Million
≈ $96.43 Million
CN¥61.28 Million
≈ $8.97 Million
0.093x -50.52%
2011-12-31 CN¥249.52 Million
≈ $36.51 Million
CN¥46.89 Million
≈ $6.86 Million
0.188x +20.11%
2010-12-31 CN¥206.00 Million
≈ $30.14 Million
CN¥32.23 Million
≈ $4.72 Million
0.156x +16.48%
2009-12-31 CN¥169.62 Million
≈ $24.82 Million
CN¥22.79 Million
≈ $3.33 Million
0.134x +13.86%
2008-12-31 CN¥135.96 Million
≈ $19.89 Million
CN¥16.04 Million
≈ $2.35 Million
0.118x -49.74%
2007-12-31 CN¥99.25 Million
≈ $14.52 Million
CN¥23.30 Million
≈ $3.41 Million
0.235x +92.14%
2006-12-31 CN¥76.95 Million
≈ $11.26 Million
CN¥9.40 Million
≈ $1.38 Million
0.122x --

About Beijing Bohui Innovation Technology Co Ltd

SHE:300318 China Biotechnology
Market Cap
$669.41 Million
CN¥4.57 Billion CNY
Market Cap Rank
#11068 Global
#3292 in China
Share Price
CN¥5.60
Change (1 day)
-0.53%
52-Week Range
CN¥5.51 - CN¥8.17
All Time High
CN¥21.16
About

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more